Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025

Clene Inc. (CLNN) announced that Rob Etherington, the company's Chief Executive Officer and President, will be presenting at the upcoming Investor Summit Virtual event scheduled for June 10, 2025.

Rhea-AI Summary

Clene Inc. (CLNN) announced that Rob Etherington, the company's Chief Executive Officer and President, will be presenting at the upcoming Investor Summit Virtual event scheduled for June 10, 2025. This virtual presentation represents an opportunity for investors to gain insights into the company's developments and strategic direction directly from its top executive.

Argus Session date unavailable

-0.71% session move Open Argus

Details

News Market Reaction – CLNN

The recorded move for CLNN in the trading session of this news was -0.71%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SALT LAKE CITY, UT / ACCESS Newswire / June 9, 2025 / Clene Inc. announced that Rob Etherington, Chief Executive Officer and President, will be presenting at the Investor Summit Virtual taking place on June 10.

About Clene Inc.
Clene Inc., (Nasdaq: CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis. CNM-Au8® is an investigational first-in-class therapy that improves central nervous system cells' survival and function via a mechanism that targets mitochondrial function and the NAD pathway while reducing oxidative stress. CNM-Au8® is a federally registered trademark of Clene Nanomedicine, Inc. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland. For more information, please visit www.clene.com or follow us onX (formerly Twitter) and LinkedIn.

Event: Q2 Investor Summit
Presentation Time:1:00 PM ET
Location: WEBCAST LINK

Conference Overview and Structure

The Investor Summit is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various subject matter experts, and see what your peers are doing in this market.

This quarter's event is focused on MicroCap companies who are undervalued, have a catalyst, and are undervalued.

Registration for Investors

To request free registration, please go to our website (https://investorsummitgroup.com/), and click the "Registration" button.

Sponsors:

• AccessNewswire

• PCG Advisory

• QuoteMedia

• AGP

• MZ Group

News Compliments of ACCESSWIRE

For More Information

Please visit: https://investorsummitgroup.com/

Or, contact johnna-mae@investorsummitgroup.com

SOURCE: Investor Summit Group

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Clene Inc. (CLNN) CEO presenting at the Investor Summit Virtual?

Clene Inc. CEO Rob Etherington will be presenting at the Investor Summit Virtual on June 10, 2025.

Who is presenting for Clene Inc. (CLNN) at the Investor Summit Virtual 2025?

Rob Etherington, Chief Executive Officer and President of Clene Inc., will be presenting at the event.

What is the upcoming investor event for Clene Inc. (CLNN)?

Clene Inc. will be participating in the Investor Summit Virtual event on June 10, 2025.

Where will the Clene Inc. (CLNN) presentation take place?

The presentation will take place virtually at the Investor Summit Virtual event.